BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19654868)

  • 1. Genetic polymorphisms of estrogen receptors alpha and beta and the risk of developing prostate cancer.
    Chae YK; Huang HY; Strickland P; Hoffman SC; Helzlsouer K
    PLoS One; 2009 Aug; 4(8):e6523. PubMed ID: 19654868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between estrogen receptor genetic polymorphisms, smoking status, and prostate cancer risk: a case-control study in Japanese men.
    Lu X; Yamano Y; Takahashi H; Koda M; Fujiwara Y; Hisada A; Miyazaki W; Katoh T
    Environ Health Prev Med; 2015 Sep; 20(5):332-7. PubMed ID: 26251204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer risk and ESR1 TA, ESR2 CA repeat polymorphisms.
    McIntyre MH; Kantoff PW; Stampfer MJ; Mucci LA; Parslow D; Li H; Gaziano JM; Abe M; Ma J
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2233-6. PubMed ID: 18006911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant role of estrogen and progesterone receptor sequence variants in gallbladder cancer predisposition: a multi-analytical strategy.
    Srivastava A; Sharma KL; Srivastava N; Misra S; Mittal B
    PLoS One; 2012; 7(7):e40162. PubMed ID: 22808109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of estrogen receptors and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China.
    Park SK; Andreotti G; Rashid A; Chen J; Rosenberg PS; Yu K; Olsen J; Gao YT; Deng J; Sakoda LC; Zhang M; Shen MC; Wang BS; Han TQ; Zhang BH; Yeager M; Chanock SJ; Hsing AW
    Carcinogenesis; 2010 May; 31(5):842-6. PubMed ID: 20172949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of genetic variants in Estrogen receptor (ESR)1 and ESR2 with susceptibility to recurrent pregnancy loss in Tunisian women: A case control study.
    Bahia W; Soltani I; Haddad A; Soua A; Radhouani A; Mahdhi A; Ferchichi S
    Gene; 2020 Apr; 736():144406. PubMed ID: 32007580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique ESR1 and ESR2 estrogen receptor gene variants associated with altered risk of triple-negative breast cancer: A case-control study.
    Sghaier I; Zidi S; El-Ghali RM; Daldoul A; Aimagambetova G; Almawi WY
    Gene; 2023 Jan; 851():146969. PubMed ID: 36261089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer.
    Hedelin M; Bälter KA; Chang ET; Bellocco R; Klint A; Johansson JE; Wiklund F; Thellenberg-Karlsson C; Adami HO; Grönberg H
    Prostate; 2006 Oct; 66(14):1512-20. PubMed ID: 16921512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.
    Leyland-Jones B; Gray KP; Abramovitz M; Bouzyk M; Young B; Long B; Kammler R; Dell'Orto P; Biasi MO; Thürlimann B; Harvey V; Neven P; Arnould L; Maibach R; Price KN; Coates AS; Goldhirsch A; Gelber RD; Pagani O; Viale G; Rae JM; Regan MM;
    Breast Cancer Res Treat; 2015 Dec; 154(3):543-55. PubMed ID: 26590813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk.
    Fu C; Dong WQ; Wang A; Qiu G
    Tumour Biol; 2014 Aug; 35(8):8319-28. PubMed ID: 24859835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited variations in AR, ESR1, and ESR2 genes are not associated with prostate cancer aggressiveness or with efficacy of androgen deprivation therapy.
    Sun T; Lee GS; Werner L; Pomerantz M; Oh WK; Kantoff PW; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1871-8. PubMed ID: 20615892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.
    Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
    J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    Chen YC; Kraft P; Bretsky P; Ketkar S; Hunter DJ; Albanes D; Altshuler D; Andriole G; Berg CD; Boeing H; Burtt N; Bueno-de-Mesquita B; Cann H; Canzian F; Chanock S; Dunning A; Feigelson HS; Freedman M; Gaziano JM; Giovannucci E; Sánchez MJ; Haiman CA; Hallmans G; Hayes RB; Henderson BE; Hirschhorn J; Kaaks R; Key TJ; Kolonel LN; LeMarchand L; Ma J; Overvad K; Palli D; Pharaoh P; Pike M; Riboli E; Rodriguez C; Setiawan VW; Stampfer M; Stram DO; Thomas G; Thun MJ; Travis RC; Virtamo J; Trichopoulou A; Wacholder S; Weinstein SJ
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1973-81. PubMed ID: 17932344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of estrogen receptor gene polymorphisms and mRNA levels on obesity and lipolysis--a cohort study.
    Nilsson M; Dahlman I; Jiao H; Gustafsson JA; Arner P; Dahlman-Wright K
    BMC Med Genet; 2007 Dec; 8():73. PubMed ID: 18053221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Int J Cancer; 2010 Jun; 126(12):2935-46. PubMed ID: 19739075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of bone mineral density with estrogen receptor gene polymorphisms.
    Greendale GA; Chu J; Ferrell R; Randolph JF; Johnston JM; Sowers MR
    Am J Med; 2006 Sep; 119(9 Suppl 1):S79-86. PubMed ID: 16949392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of estrogen receptor gene variants (ESR1 and ESR2) with polycystic ovary syndrome in Tunisia.
    Douma Z; Dallel M; Bahia W; Ben Salem A; Hachani Ben Ali F; Almawi WY; Lautier C; Haydar S; Grigorescu F; Mahjoub T
    Gene; 2020 May; 741():144560. PubMed ID: 32169631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variants of estrogen receptor alpha and beta genes modify the severity of sporadic breast cancer.
    Rezende LM; Marson FA; Lima CS; Bertuzzo CS
    Gene; 2017 Apr; 608():73-78. PubMed ID: 28109853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of the estrogen receptors 1 and 2 gene polymorphisms with the metabolic syndrome in women.
    Goulart AC; Zee RY; Pradhan A; Rexrode KM
    Metab Syndr Relat Disord; 2009 Apr; 7(2):111-7. PubMed ID: 19032032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-specific effects of estrogen receptors' polymorphisms on the bone traits in healthy fertile women: the BONTURNO study.
    Massart F; Marini F; Bianchi G; Minisola S; Luisetto G; Pirazzoli A; Salvi S; Micheli D; Masi L; Brandi ML
    Reprod Biol Endocrinol; 2009 Apr; 7():32. PubMed ID: 19386104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.